Current and novel therapeutic molecules and targets in Alzheimer's disease

Current and novel therapeutic molecules and targets in Alzheimer's disease

Alzheimer's disease (AD) is a neurodegenerative disorder in which the death of brain cells causes memory loss and cognitive decline, i.e., dementia. The disease starts with mild symptoms and gradually becomes severe. AD is one of the leading causes of mortality worldwide. Several different hall...

Full description

Bibliographic Details
Main Authors:	Ashwini Kumar, Chaluveelaveedu Murleedharan Nisha, Chitrangda Silakari, Isha Sharma, Kanukanti Anusha, Nityasha Gupta, Prateek Nair, Timir Tripathi, Awanish Kumar
Format:	Article
Language:	English
Published:	Elsevier 2016-01-01
Series:	Journal of the Formosan Medical Association
Subjects:	Alzheimer's disease drug targets inhibitors molecular docking therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664615001497

Similar Items

Computational Study of Natural Compounds for the Clearance of Amyloid-Βeta: A Potential Therapeutic Management Strategy for Alzheimer’s Disease
by: Syed Sayeed Ahmad, et al.
Published: (2019-09-01)

A strategy to find novel candidate anti-Alzheimer’s disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants
by: Bi-Wen Chen, et al.
Published: (2018-05-01)

Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis
by: Johant Lakey-Beitia, et al.
Published: (2019-11-01)

The exploration of novel Alzheimer’s therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches
by: Mubashir Hassan, et al.
Published: (2019-01-01)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
by: Jangampalli Adi Pradeepkiran, et al.
Published: (2019-03-01)

2-(2-(4-Benzoylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives: Synthesis, docking and acetylcholinesterase inhibitory evaluation as anti-alzheimer agents
by: Ahmad Mohammadi-Farani, et al.
Published: (2017-01-01)

Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation
by: Nitin Chitranshi, et al.
Published: (2021-07-01)

Computer-assisted evaluation of plant-derived β-secretase inhibitors in Alzheimer’s disease
by: Md. Asad Ullah, et al.
Published: (2021-04-01)

Comparative Evaluation of the Antioxidant and Anti-Alzheimer’s Disease Potential of Coumestrol and Puerarol Isolated from Pueraria lobata Using Molecular Modeling Studies
by: Prashamsa Koirala, et al.
Published: (2018-03-01)

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
by: Óscar M. Bautista-Aguilera, et al.
Published: (2020-05-01)

Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease
by: Weiam Hussein, et al.
Published: (2018-08-01)

Inhibition of GSK_3β by Iridoid Glycosides of Snowberry (Symphoricarpos albus) Effective in the Treatment of Alzheimer’s Disease Using Computational Drug Design Methods
by: Marzieh Eskandarzadeh, et al.
Published: (2021-10-01)

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
by: Minky Son, et al.
Published: (2019-02-01)

Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer’s disease: a computational approach
by: Bishajit Sarkar, et al.
Published: (2021-02-01)

Design, Synthesis, and Structure–Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer’s Disease
by: Begüm Nurpelin Sağlık, et al.
Published: (2020-09-01)

Effects of P-Glycoprotein on the Transport of DL0410, a Potential Multifunctional Anti-Alzheimer Agent
by: Xiaocong Pang, et al.
Published: (2017-07-01)

Network pharmacology used to decode potential active ingredients in Ferula assafoetida and mechanisms for the application to Alzheimer’s disease
by: Meng Xu, et al.
Published: (2020-04-01)

High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer’s disease using computational approaches
by: Rohit Shukla, et al.
Published: (2021-05-01)

Tocopherol from seeds of Cucurbita pepo against diabetes: Validation by in vivo experiments supported by computational docking
by: Sudhanshu Kumar Bharti, et al.
Published: (2013-11-01)

Small molecule biomarkers in Alzheimer’s disease
by: Kim Min, et al.
Published: (2018-07-01)

Multitarget Approach to Drug Candidates against Alzheimer’s Disease Related to AChE, SERT, BACE1 and GSK3β Protein Targets
by: Larisa Ivanova, et al.
Published: (2020-04-01)

Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer’s Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches
by: Oluwafemi Adeleke Ojo, et al.
Published: (2021-04-01)

Network Pharmacology-Based Analysis of Xiao-Xu-Ming Decoction on the Treatment of Alzheimer’s Disease
by: Yanjia Shen, et al.
Published: (2020-12-01)

Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease
by: Chen Zhang, et al.
Published: (2018-01-01)

Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia – An in vitro and in silico study
by: Dicson Sheeja Malar, et al.
Published: (2017-01-01)

Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
by: Jie Zhu, et al.
Published: (2018-01-01)

A Network-Based Approach to Explore the Mechanisms of <i>Uncaria</i> Alkaloids in Treating Hypertension and Alleviating Alzheimer’s Disease
by: Wenyong Wu, et al.
Published: (2020-03-01)

Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer’s Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches
by: Xiaocong Pang, et al.
Published: (2017-07-01)

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
by: Yan Guo, et al.
Published: (2020-01-01)

Design, Synthesis, and Biological Activity Evaluation of New Donepezil-like Compounds Bearing Thiazole Ring for the Treatment of Alzheimer’s Disease
by: Begüm Nurpelin Sağlık, et al.
Published: (2020-07-01)

Effective Use of Empirical Data for Virtual Screening against APJR GPCR Receptor
by: Laura C. E. Manoliu, et al.
Published: (2021-08-01)

Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease
by: Eliška Kohelová, et al.
Published: (2019-04-01)

Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies
by: Niraj Kumar Jha, et al.
Published: (2020-12-01)

Anti-Acetylcholinesterase Activities of Mono-Herbal Extracts and Exhibited Synergistic Effects of the Phytoconstituents: A Biochemical and Computational Study
by: Acharya Balkrishna, et al.
Published: (2019-11-01)

Exploitation of Marine Molecules to Manage Alzheimer’s Disease
by: Marisa Silva, et al.
Published: (2021-06-01)

Pharmacological Mechanisms Underlying the Neuroprotective Effects of <i>Alpinia oxyphylla</i> Miq. on Alzheimer’s Disease
by: Jia Xu, et al.
Published: (2020-03-01)

Differentiating Alzheimer disease-associated aggregates with small molecules
by: Nicolette S. Honson, et al.
Published: (2007-12-01)

Repositioning Drugs to the Mitochondrial Fusion Protein 2 by Three-Tunnel Deep Neural Network for Alzheimer's Disease
by: Xun Wang, et al.
Published: (2021-02-01)

MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
by: Anas Shamsi, et al.
Published: (2020-05-01)

Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases
by: Anas Shamsi, et al.
Published: (2019-09-01)

Cannot write session to /tmp/vufind_sessions/sess_tljrkaevkq049raqd6uvpmf9j6